Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 Pandemic

OBJECTIVE: Patients with rheumatic diseases such as rheumatoid arthritis (RA) and lupus have increased risk of infection and are treated with medications that may increase this risk yet are also hypothesized to help treat COVID‐19. We set out to understand how the COVID‐19 pandemic has impacted the...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaud, Kaleb, Wipfler, Kristin, Shaw, Yomei, Simon, Teresa A., Cornish, Adam, England, Bryant R., Ogdie, Alexis, Katz, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264613/
https://www.ncbi.nlm.nih.gov/pubmed/32311836
http://dx.doi.org/10.1002/acr2.11148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264613/
https://www.ncbi.nlm.nih.gov/pubmed/32311836
http://dx.doi.org/10.1002/acr2.11148

Ejemplares similares